Since the GDPR enforcement date, what barriers to compliance are organisations continuing to face, and how are they addressing this?
About Rich JinksThis author has not yet filled in any details.
So far Rich Jinks has created 36 blog entries.
Learn why requirements for plain-language summaries of clinical studies, aimed at a broad, non-technical audience, could create new risks for sponsors.
Trust is a significant issue in Pharma. Blockchain could solve this problem and more in clinical trials, increasing transparency and saving time.
Learn how leading organisations are engaging patients from trial design to study close-out to create a holistic framework for improving patient experience.
Blockchain could revolutionise the pharma supply chain, solving big issues in logistics, counterfeiting, and patient usage. Follow the link to find out how.
Threatened by innovative biotech organisations, Pharma companies need to accelerate their patient centricity initiatives or risk falling behind.